Posted February 14, 2013 in Injection Treatments
Different treatments have different effects Botox is a pretty universally popular cosmetic treatment, even among those who want to try plastic surgery, yet never have. As versatile as it is, though, it’s not a cure-all for facial flaws. Some people might want fuller lips, for example, and assume Botox is good for that. Not so. […]
Read MorePosted January 18, 2013 in Plastic Surgery
Projected trends for the new year. The new year is right around the corner. After the world’s finished singing Auld Lanf Syne, economists, doctors and analysts won’t hesitate to posit what the coming year’s trends might be in the world of plastic surgery. Here’s an early round-up of what the experts expect to see down […]
Read MorePosted April 04, 2011 in Injection Treatments
Botox and Dysport may soon have competition in your surgeon’s office if early trials of a wrinkle freezing treatment see continued success, according to U.S. News. Though both Botox and Dysport are hugely popular non-surgical options for diminishing many facial lines and wrinkles, new alternatives are often being researched. This treatment, which is called cryoneuromodulation, […]
Read MorePosted March 07, 2011 in Injection Treatments
It’s certainly not news that wrinkle-reducing injectables like Botox and Dysport are seeing sales increases as the economy rebounds. It is noteworthy, however, what the companies are working toward in the wake of renewed consumer interest—topical versions, according to bnet.com. Botox, produced by Allergan and Dysport, produced by Medicis, contain similar components of the botulinum […]
Read MorePosted September 06, 2010 in Injection Treatments
Medicis, pharmaceutical giant and makers of the popular wrinkle filler Restylane, launched a rebate promotion in March 2010 to promote its injectable wrinkle relaxer and Botox competitor Dysport. To date, more than 100,000 patients have taken the so-called “Dysport Challenge.” The Dysport Challenge promotion essentially rewards patients who report whether they were satisfied with their Dysport […]
Read MorePosted August 06, 2010 in Injection Treatments
Xeomin, a botulinum type A injectable treatment made by German pharmaceutical giant Merz, was finally FDA-approved to join Botox and Dysport on the U.S. market in late September, after having been available in Europe since 2008. Xeomin will likely compete with Botox and Dysport for a share of patients seeking to reduce forehead creases and […]
Read MorePosted May 03, 2009 in Injection Treatments
A new Botox competitor from Ipsen and Medicis Pharmaceutical has received FDA approval for treating wrinkles and dystonia. Plastic surgeons and dermatologists may have the drug available for cosmetic use in just 30 – 60 days. Rather than rebranding the drug ‘Reloxin’ as planned, Medicis decided to retain its original European name, Dysport The April […]
Read MoreContact Us
We Would Love To Hear From You
